Zhang, H.; Li, Y.; Li, J.; Li, X.; Li, T.
Base and Prime Editing for Inherited Retinal Diseases: Delivery Platforms, Safety, Efficacy, and Translational Perspectives. Pharmaceutics 2025, 17, 1405.
https://doi.org/10.3390/pharmaceutics17111405
AMA Style
Zhang H, Li Y, Li J, Li X, Li T.
Base and Prime Editing for Inherited Retinal Diseases: Delivery Platforms, Safety, Efficacy, and Translational Perspectives. Pharmaceutics. 2025; 17(11):1405.
https://doi.org/10.3390/pharmaceutics17111405
Chicago/Turabian Style
Zhang, Haoliang, Yuxuan Li, Jiajie Li, Xiaosa Li, and Tong Li.
2025. "Base and Prime Editing for Inherited Retinal Diseases: Delivery Platforms, Safety, Efficacy, and Translational Perspectives" Pharmaceutics 17, no. 11: 1405.
https://doi.org/10.3390/pharmaceutics17111405
APA Style
Zhang, H., Li, Y., Li, J., Li, X., & Li, T.
(2025). Base and Prime Editing for Inherited Retinal Diseases: Delivery Platforms, Safety, Efficacy, and Translational Perspectives. Pharmaceutics, 17(11), 1405.
https://doi.org/10.3390/pharmaceutics17111405